Atlas Venture Opportunity Fund Ii, L.P. Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

Atlas Venture Opportunity Fund Ii, L.P. is > 10% Shareholder of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 766,667 shares of DAWN, which is worth approximately $9.97 Million. The most recent transaction as insider was on Jun 17, 2022, when has been sold 766,667 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $11,500,005. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 767K

0% 3M change

0% 12M change

Total Value Held $9.97 Million

Atlas Venture Opportunity Fund II, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 17 2022	BUY Open market or private purchase	$11,500,005 $15.0 p/Share	766,667 Added 50.0%	766,667 Common Stock

Also insider at

DYN

Dyne Therapeutics, Inc. Healthcare

> 10% Shareholder

FREQ

Frequency Therapeutics, Inc. Healthcare

AVO